跳至主要内容
临床试验/NCT03060057
NCT03060057进行中(未招募)不适用

Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System - "U-Propel Study"

United Orthopedic Corporation4 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年3月30日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200
试验地点
4
主要终点
Implant Survivorship

研究概览

简要总结

The purpose of this study is to evaluate both short and long term clinical performance and safety of the commercially available U2 Knee™ System.

详细描述

This is a prospective, single arm, multi-center, post-approval study designed to evaluate the short and long term clinical performance and safety in subjects receiving primary total knee arthroplasty (TKA) with the U2 Knee™ System. The study will enroll up to 200 subjects with scheduled pre-discharge, 6-week, 3- and 6-month and up to 5-year annual follow-up visits. Study outcomes will be analyzed and published when 1.) all enrolled and implanted subjects complete their 6-week follow up, 2.) all implanted subjects complete their 2-year follow up, 3.) at the conclusion of the study.

The study will follow GCP guidelines and will be registered on clinicaltrials.gov.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is between 18 and 75 years of age
  • Subject is indicated for a unilateral total knee arthroplasty (TKA) based on the approved labeling of the device
  • Subject has no history of previous prosthetic replacement device or orthopedic surgeries on the operative knee
  • Subject is willing and able to provide informed consent to participate in the study;
  • Subject is willing and able to understand the purpose of the study, his/her role, and is available to return to the clinic/hospital for all required follow-up visits;

排除标准

  • Subjects will be excluded if, in the opinion of the Investigator, the subject does not qualify based on approved labeling requirements or Subject Inclusion criteria.

结局指标

主要结局

Implant Survivorship

时间窗: 2 Years

Device Survivorship defined as no revision of removal of any parts of the system

次要结局

  • Change in EQ-5D Over Time(Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, 5 years)
  • Change in EQ-5D VAS Over Time(Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, 5 years)
  • Radiographic Analysis(24 months, 5 years)
  • Subject Satisfaction Survey(6 weeks, 3 months, 6 months, 12 months, 2 Years, 3 Years, 4 Years and 5 Years.)
  • Change in KOOS, JR. Over Time(Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, 5 years)
  • Change in Knee Society Score (KSS) Over Time(Baseline, 6 weeks, 3 months, 6 months, 12 months, 24 months, 3 years, 4 years, 5 years)
  • Operative characteristics(Operative)

研究者

发起方
United Orthopedic Corporation
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验